Dan Benjamin Teleman
CEO at Nasus Pharma Ltd (NSRX)
Purchase track record
Market-like. Based on 3 purchases with a full 90 days of price history.
51
Avg. 90-day return+8.5%
vs. S&P 500+0.5%
Beat the market67%
Paper profit on buys+$24K
Total bought / sold$62K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 22SEC | NSRXNasus Pharma Ltd | Buy | 6,550163,541 held (+4%) | $3.10 | $20K | +13.2% |
| Apr 22SEC | NSRXNasus Pharma Ltd | Buy | 2,900156,991 held (+2%) | $3.76 | $11K | -6.6% |
| Apr 1SEC | NSRXNasus Pharma Ltd | Buy | 15,00021,246 held (+240%) | $2.04 | $31K | +72.1% |
- Buy
CEO Dan Benjamin Teleman bought $31K of NSRX at $2.04 — first open-market purchase in our records; raises the stake by 240%.